- We are at the forefront of using the latest image-guided techniques to diagnose prostate cancer.
- Our multidisciplinary prostate cancer program brings together expertise from a diverse group of specialists.
- We have a growing prostate cancer research program.
A diagnosis of prostate cancer can be frightening, but thanks to treatment advances, the five-year survival rate for all stages of prostate cancer is almost 100 percent, according to the American Cancer Society. The 10-year and 15-year survival rates are 98 percent and 95 percent respectively.
Radiation therapy is commonly used to treat this type of cancer. At Yale Medicine, our radiation oncologists are at the forefront of diagnosing and treating all types and stages of prostate cancer We continually evaluate new radiation technologies and conduct research to ensure that our patients receive the most cutting-edge treatment available.